Literature DB >> 7868906

In vivo regulation of rat neutrophil apoptosis occurring spontaneously or induced with TNF-alpha or cycloheximide.

H Tsuchida1, Y Takeda, H Takei, H Shinzawa, T Takahashi, F Sendo.   

Abstract

We previously demonstrated that human TNF-alpha induces rapid apoptosis of human neutrophils. To understand better the in vivo significance of neutrophil apoptosis, we examined spontaneous, recombinant human and mouse TNF-alpha- or cycloheximide-induced apoptosis of normal peripheral blood neutrophils (PBN), PBN from rats injected i.p. with proteose peptone or a streptococcus preparation, OK-432 (inflammatory PBN), peritoneally exudated neutrophils (PEN) obtained after a proteose peptone injection, and normal bone marrow neutrophils. The following observations were made. 1) Normal PBN responded to TNF-alpha, but PEN, normal bone marrow neutrophils, and inflammatory PBN at 12 h after stimulation did not. 2) The sensitivity to TNF-alpha of the inflammatory PBN started to decrease at 3 h, was lowest at 12 h, and was almost restored at 52 h after stimulation. 3) Spontaneous apoptosis of normal and inflammatory PBN reached 25% at 12 h after in vitro incubation, but that of PEN and normal bone marrow neutrophils was very low over this period. 4) The sensitivity to cycloheximide (6 h incubation) was high for normal PBN and bone marrow neutrophils, but low for PEN and inflammatory PBN after 12 h. 5) 125I-rhTNF-alpha binding of bone marrow neutrophils was significantly lower than that of normal and inflammatory PBN and PEN. 6) TNF-alpha-induced apoptosis of normal or inflammatory PBN and bone marrow neutrophils was enhanced by treatment with low doses of cycloheximide that alone were barely able to induce neutrophil apoptosis; however, apoptosis of PEN was not. The mechanisms and in vivo significance of these phenomena are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7868906

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

Review 1.  Peculiarities of cell death mechanisms in neutrophils.

Authors:  B Geering; H-U Simon
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

Review 2.  Mechanisms of immune resolution.

Authors:  Alfred Ayala; Chun-Shiang Chung; Patricia S Grutkoski; Grace Y Song
Journal:  Crit Care Med       Date:  2003-08       Impact factor: 7.598

3.  Virus-infected alveolar epithelial cells direct neutrophil chemotaxis and inhibit their apoptosis.

Authors:  Joanna P Rzepka; Anoria K Haick; Tanya A Miura
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02-03       Impact factor: 6.914

4.  A novel therapeutic strategy for attenuating neutrophil-mediated lung injury in vivo.

Authors:  Shastri Sookhai; Jiang Juai Wang; Morgan McCourt; William Kirwan; David Bouchier-Hayes; Paul Redmond
Journal:  Ann Surg       Date:  2002-02       Impact factor: 12.969

5.  PATHOLOGICAL ASPECTS OF THE ANTI-INFLAMMATORY/IMMUNE SUPPRESSIVE RESPONSE IN SEPSIS AND SHOCK.

Authors:  Alfred Ayala; Yanli Ding; Rebecca J Rhee; Lesley A Doughty; Patrician S Grutkoski; Chun-Shiang Chung
Journal:  Rec Res Dev Immunol       Date:  2003-01-12

6.  Regulation of systemic and local neutrophil responses by G-CSF during pulmonary Pseudomonas aeruginosa infection.

Authors:  Alyssa D Gregory; Lisa A Hogue; Thomas W Ferkol; Daniel C Link
Journal:  Blood       Date:  2006-12-21       Impact factor: 22.113

7.  Thalidomide analogue CC-3052 reduces HIV+ neutrophil apoptosis in vitro.

Authors:  M Guckian; I Dransfield; P Hay; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

8.  Intraperitoneal injection of lipopolysaccharide induces dynamic migration of Gr-1high polymorphonuclear neutrophils in the murine abdominal cavity.

Authors:  Shuichi Miyazaki; Fumio Ishikawa; Toshihiko Fujikawa; Shigekazu Nagata; Keizo Yamaguchi
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

9.  Ethyl pyruvate ameliorates endotoxin-induced corneal inflammation.

Authors:  Divya Gupta; Yiqin Du; Jordan Piluek; Adam M Jakub; Kristine Ann Buela; Akshar Abbott; Joel S Schuman; Nirmala SundarRaj
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-25       Impact factor: 4.799

10.  Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents.

Authors:  Jian Ren; Naoki Agata; Dongshu Chen; Yongqing Li; Wei-hsuan Yu; Lei Huang; Deepak Raina; Wen Chen; Surender Kharbanda; Donald Kufe
Journal:  Cancer Cell       Date:  2004-02       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.